Technology lightens the burden of diabetes

accreditation
Insulin pump from Shutterstock
Insulin pump from Shutterstock

Technology can ease some of the burden of managing diabetes, possibly getting blood sugar levels within safe ranges more often, the U.S. Food and Drug Administration says.

Steady flow of insulin


People with diabetes don't make or use the hormone insulin properly. Insulin is needed to convert glucose from food into energy.

Insulin pumps are devices that deliver a steady flow of insulin, even while you sleep. The pump is about the size of a pager and is worn outside the body. It's connected to a tube that carries insulin from the pump to another tube inserted just under the skin. This tube has to be changed every few days.

There are a number of FDA-approved insulin pumps on the market, including one that's wireless. Called a patch pump, this device holds insulin in a pod worn on the body with a tiny tube inserted underneath the skin every few days. Insulin delivery is controlled through a handheld device, according to the product's manufacturer.

Read: Insulin pumps better for diabetic kids

Another device that helps with blood sugar management is a continuous glucose monitor (CGM). It has sensors that check your glucose (blood sugar) levels every five minutes, according to the FDA. The readings are sent wirelessly to a receiver. You still need to manually check your blood sugar periodically, but CGMs help to show whether blood sugar is rising, falling or staying the same.

Less equipment

There are also CGM-enabled insulin pumps that communicate wirelessly with a CGM. The sensor readings are displayed on the insulin pump screen instead of on a separate receiver, which means patients have to carry one less piece of equipment, the FDA said.

Read: Diabetics beware when travelling by air

"These devices are an important technological advance to address some of the challenges people with diabetes face in managing their blood sugar," Alberto Gutierrez, director of FDA's Office of In Vitro Diagnostics and Radiological Health, said in an agency news release.

"As they become better integrated with insulin pumps, CGMs can ease the daily burden of people with diabetes who juggle the use of multiple medical devices," he added.

Scientists are also working on artificial pancreas device systems, which combine a CGM and an insulin pump with a sophisticated computer programme that predicts blood sugar levels and insulin needs. These systems monitor blood sugar levels and automatically pump appropriate doses of insulin when needed, according to the FDA.


Read more:

Insulin pumps may outperform insulin injections
US FDA seeks ways to minimise insulin pump risks
Sensor helps prevent nighttime hypoglycaemia

Image: Insulin pump from Shutterstock

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
Eskom has considered continuous load shedding at Stage 2, instead of introducing it when the power system faces a crunch. What are your thoughts?
Please select an option Oops! Something went wrong, please try again later.
Results
I'm all for it - we're going to have power cuts regardless, so we might as well have some stability to better plan our lives
45% - 4125 votes
No thanks! I prefer having periods of no load shedding and we cannot normalise this crisis
55% - 5000 votes
Vote
Rand - Dollar
17.93
-1.8%
Rand - Pound
19.45
-0.0%
Rand - Euro
17.37
-0.0%
Rand - Aus dollar
11.70
-0.0%
Rand - Yen
0.13
-0.0%
Gold
1,643.66
0.0%
Silver
18.87
0.0%
Palladium
2,073.00
0.0%
Platinum
858.50
0.0%
Brent Crude
86.15
-5.0%
Top 40
57,110
-3.1%
All Share
63,417
-2.9%
Resource 10
56,319
-7.5%
Industrial 25
78,436
-1.2%
Financial 15
14,142
-1.6%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE